About
Contact & Profiles
A5063176553
Research Areas
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- RNA modifications and cancer
- Antimicrobial Resistance in Staphylococcus
- Peptidase Inhibition and Analysis
- Microbial Natural Products and Biosynthesis
- Antibiotic Resistance in Bacteria
Fudan University
2022
State Key Laboratory of Genetic Engineering
2022
Despite remarkable advances in treatment, most patients with hepatocellular carcinoma (HCC) respond poorly to anti-programmed cell death 1 (anti-PD1) therapy. A deeper insight into the tolerance mechanism of HCC against this therapy is urgently needed.We performed next-generation sequencing, multiplex immunofluorescence, and dual-color immunohistochemistry constructed an orthotopic xenograft tumor model identify key gene associated anti-PD1 tolerance. spontaneously tumorigenic transgenic...
10.1016/j.jhep.2022.02.019
article
EN
cc-by-nc-nd
Journal of Hepatology
2022-02-24
10.1016/j.jgar.2022.05.026
article
EN
Journal of Global Antimicrobial Resistance
2022-06-02
Coming Soon ...